China's Sinopharm COVID-19 jab, which is approved in more than 50 countries, produces less protective antibodies against coronavirus in elderly people, a study revealed.
from Medindia Health News https://ift.tt/3iM0l7Y
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
July 26, 2021
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.